Hearing aids and hearing care

“The key components of each revenue category are as follows: •Computing and Mobile Phones - computing (including desktops, notebooks and peripherals), mobile phones (including related mobile network carrier commissions), networking, tablets (including e-readers) and wearables (including smartwatches); •Consumer Electronics - digital imaging, health and fitness products, home theater (including home theater accessories, soundbars and televisions), portable audio (including headphones and portable speakers) and smart home; •Appliances - large appliances (including dishwashers, laundry, ovens and refrigerators) and small appliances (including blenders, coffee makers, vacuums and personal care); •Entertainment - drones, gaming (including hardware, peripherals and software, as well as augmented reality glasses), toys, virtual reality and other software; •Services - advertising, delivery, health-related services, installation, marketplace commissions, memberships, repair, set-up, technical support, warranty-related services; and •Other - other product offerings, including baby, food and beverage and outdoor living.”

Annual report 2026A · The company itself

“The Domestic segment is comprised of our operations in all states, districts and territories of the U.S. and our Best Buy Health business, and includes the brand names Best Buy, Best Buy Ads, Best Buy Business, Best Buy Essentials, Best Buy Health, Best Buy Marketplace, Geek Squad, Imagine That, Insignia, Lively, Jitterbug, My Best Buy, My Best Buy Memberships, Pacific Kitchen and Home, TechLiquidators and Yardbird; and the domain names bestbuy.com, lively.com, techliquidators.com and yardbird.com.”

Annual report 2026A · The company itself

“CASE Innehav i fokus Från noll till två miljarder på fem år – Safe Lifes snabba tillväxtresa räddar liv Varje år drabbas omkring 6 000 personer i Sverige av plötsligt hjärtstopp utanför sjukhus. Endast ca 10% överlever.”

Annual report 2024A · The company itself

“Reported growth in DKK Reported revenue included a negative effect from FX rates HyperlinkHy perlinkHyper linkHyperlink Hyperlink Voice & Respiratory Care generated 9% organic sales growth for the financial year 2024/25. Reported revenue in DKK grew by 8% to DKK 2,280 million, in line with our acquisition case.”

Annual report 2025A · The company itself

“Laryngectomy delivered high single-digit growth in full year 2024/25. Growth was driven by an increase in the number of patients served in existing and new markets and an increase in patient value driven by the Provox Life portfolio, Voice & Respiratory Care’s product line launched in 2019, which allows for a personalised regime.”

Annual report 2025A · The company itself

“Tracheostomy delivered double-digit growth, driven by solid demand and an increase in the number of patients served.”

Annual report 2025A · The company itself

“EXTERNAL REVENUE IN 2025 9,841 DKK MILLION”

Annual report 2025A · The company itself

“This is Demant 11 Event highlights in 2025 13 Overview Overview We are guided by our purpose and strategic ambition to create life-changing differences through hearing health.”

Annual report 2025A · The company itself

“Our business is based on a long-term and well-defined demand for state-of-the-art hearing aids, diagnostic solutions and personalised care.”

Annual report 2025A · The company itself

“By combining Demant’s innovative hearing aid technology and diagnostic equipment with professionalised hearing care, we cover the entire journey – from diagnosis and acceptance of hearing loss to getting a hearing aid – helping more people, faster and better.”

Annual report 2025A · The company itself

“Hearing Aids generated organic revenue growth of 2% in 2025, and we expect the business area to see improvements in 2026. This will be driven by Oticon Zeal and additional new products to be launched during the year, as we prepare for an intense competitive environment where everyone will fight even harder to compensate for the soft market.”

Annual report 2025A · The company itself

“In 2025, 1.6 million people were tested for hearing loss in our clinics, and we improved more than 12.1 million lives with Demant’s hearing aids.”

Annual report 2025A · The company itself

“Hearing 7,214 ... Revenue by division ... 43% Hearing”

Annual report 2025B · From the report

“The underlying margin expansion for 2026 is supporting the journey towards the structural margin target level of 16-17%.”

Annual report 2025A · The company itself

“Gross profit reached DKK 4,407 million compared to DKK 4,458 million in 2024, corresponding to a gross margin of 61.1% in 2025. The decline in gross margin was mainly due to an adverse development from country and business mix as well as the divestment of Dansk HøreCenter in 2024.”

Annual report 2025A · The company itself

“(DKKm) 7,104 7,214 2024 +5% Organic revenue growth -2% -1% M&A growth 2025 +2% 62.8% 2024 61.1% 2025 4,458 4,407 34.7% 2024 33.6% 2025 2,464 2,421 Content Strong channel execution led to positive sell-out growth outside of Europe, while market shares were maintained in a difficult European market.”

Annual report 2025A · The company itself

“Avstämning av alternativa nyckeltal 99 Femårsöversikt 100 En historia av stadig tillväxt 102 Finansiell kalender ÖVERSIKT INVISIO utvecklar och marknadsför avancerade kommunikationssystem som hjälper yrkesgrupper i bullriga och uppdragskritiska miljöer att arbeta säkrare och effektivare, samtidigt som deras hörsel skyddas.”

Annual report 2024A · The company itself

“Lång livscykel för produkter Exempel på områden och produkter › Astma (inhalatorer, backventiler) › Diabetes (insulinpennor, infusionsset) › Hörselhjälpmedel (tätningar, öronsnäckor) › Hjärtrytmbehandling (tätningar till pacemakers, hjärtförankrare) › Dialys (tätningar, kopplingar) › Urologi (urinkatetrar, uridomer) › Kirurgi (kateterballonger, kompletta blodreningsutrustningar) › Diagnostik (PCR tester, blodanalyser, allergitester).”

Annual report 2024A · The company itself

“Aamupala- ja välipalatuotteissa kärkibrändimme on Elovena® ja sydänterveyden puolestaan Benecol®.”

Annual report 2025A · The company itself

“ITEM 1 BUSINESS General We are a global leader in digital health and cloud-connected medical devices. We design innovative technology to empower people to live happier, healthier lives. Our artificial intelligence, or AI, powered digital health solutions, cloud-connected devices and intelligent software are designed to make home healthcare more personalized, accessible and effective.”

Annual report 2026A · The company itself

“Following our formation in 1989, we commercialized a continuous positive airway pressure, or CPAP, treatment for obstructive sleep apnea, or OSA, which was the first successful non-invasive treatment for OSA. CPAP systems deliver pressurized air, typically through a mask, to prevent collapse of the upper airway during sleep. Since the development of CPAP, we have expanded our business by developing or acquiring a number of innovative products and solutions for a broad range of sleep and related breathing health disorders including technologies to be applied in medical and consumer products, life support and ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, and dental devices.”

Annual report 2026A · The company itself

“Sedana Medical AB (publ) är en pionjär inom medicinteknik och läkemedel med fokus på inhalationssedering för att förbättra patientens liv under och efter sedering. Genom kombinationen av den medicintekniska produkten Sedaconda ACD och läkemedlet Sedaconda (isofluran), tillhandahåller Sedana Medical en effektiv, enkel och förutsägbar metod för inhalations sedering av mekaniskt ventilerade patienter i intensivvård.”

Annual report 2024A · The company itself

“Hörseltest och hörapparater utgör ett marknadssegment som gränsar till de tjänster och produkter som Synsam erbjuder för ögonhälsa. I Europa och även Nordamerika är ett kombinerat erbjudande vanligt, något som ännu inte är fallet på den nordiska marknaden.”

Annual report 2024A · The company itself

“Synsam är ett ledande och lönsamt livsstilsföretag inom optik och ögonhälsa i Norden.”

Annual report 2024A · The company itself

“I erbjudandet ingår också glasögon- och kontaktlinsabonnemang, hörsel- och synundersökningar, fysiska och online, liksom personlig stilrådgivning vid utprovning av glasögon.”

Annual report 2024A · The company itself

“Det första steget i detta är Synsam Hörsel, en verksamhet som erbjuder hörseltest och hörapparater i utvalda butiker.”

Annual report 2024A · The company itself

“U.S. operating segment U.S. segment revenue increased by $23 million in 2025, which was relatively flat compared with 2024, of which $166 million resulted from growth in companion animal products, partially offset by a $143 million decline in livestock products. •Companion animal revenue growth was primarily due to increased sales of Simparica Trio, key dermatology products and small animal diagnostics, partially offset by lower sales of Librela. •Livestock revenue declined due to the impact of the MFA divestiture across cattle, poultry and swine products.”

Annual report 2025A · The company itself